BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/10/2014 7:09:00 PM | Browse: 571 | Download: 416
Publication Name World Journal of Gastroenterology
Manuscript ID 9956
Country/Territory Italy
Received
2014-03-06 09:58
Peer-Review Started
2014-03-06 15:02
To Make the First Decision
2014-04-28 14:17
Return for Revision
2014-05-03 19:26
Revised
2014-05-16 19:03
Second Decision
2014-06-23 10:08
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-23 10:15
Articles in Press
2014-06-23 10:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-10-27 14:59
Publish the Manuscript Online
2014-11-10 19:10
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Topic Highlights
Article Title MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease
Manuscript Source Invited Manuscript
All Author List Nadia Panera, Daniela Gnani, Annalisa Crudele, Sara Ceccarelli, Valerio Nobili and Anna Alisi
Funding Agency and Grant Number
Corresponding author Dr. Anna Alisi, Liver Research Unit, “Bambino Gesù” Children’s Hospital, IRCCS, P.le S. Onofrio 4, 00165 Rome, Italy. anna.alisi@opbg.net
Keywords Liver steatosis; Fibrosis; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; MicroRNAs
Core Tip Genetic background, epigenetic mechanisms and environmental factors contribute to Non-alcoholic fatty liver disease (NAFLD) development and progression. Among epigenetic mechanisms microRNAs are the most studied in NAFLD, contributing to metabolic dysfunction and liver damage. As during the last five years several authors investigated the role of microRNAs as potential therapeutic targets and/or non-invasive biomarkers we believe that this mini-review could be a good tool for researchers that critically approach this topic.
Publish Date 2014-11-10 19:10
Citation Panera N, Gnani D, Crudele A, Ceccarelli S, Nobili V, Alisi A. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(41): 15079-15086
Url http://www.wjgnet.com/1007-9327/full/v20/i41/15079.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i41.15079
Full Article (PDF) WJG-20-15079.pdf
Full Article (Word) WJG-20-15079.doc
Manuscript File 9956-Review.doc
Answering Reviewers 9956-Answering reviewers.pdf
Copyright License Agreement 9956-Copyright assignment.pdf
Peer-review Report 9956-Peer review.pdf
Scientific Misconduct Check 9956-CorssCheck.jpg
Scientific Editor Work List 9956-Scientific editor work list.pdf